1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Hashim D, Boffetta P, La Vecchia C, Rota
M, Bertuccio P, Malvezzi M and Negri E: The global decrease in
cancer mortality: Trends and disparities. Ann Oncol. 27:926–933.
2016. View Article : Google Scholar : PubMed/NCBI
|
3
|
Wang L, Yu C, Liu Y, Wang J, Li C, Wang Q,
Wang P, Wu S and Zhang ZJ: Lung cancer mortality trends in China
from 1988 to 2013: New challenges and opportunities for the
government. Int J Environ Res Public Health. 13:E10522016.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Stratton MR, Campbell PJ and Futreal PA:
The cancer genome. Nature. 458:719–724. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Ansari J, Yun JW, Kompelli AR, Moufarrej
YE, Alexander JS, Herrera GA, Herrera GA and Shackelford RE: The
liquid biopsy in lung cancer. Genes Cancer. 7:355–367.
2016.PubMed/NCBI
|
6
|
MacConaill LE and Garraway LA: Clinical
implications of the cancer genome. J Clin Oncol. 28:5219–5228.
2010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Prensner JR, Iyer MK, Balbin OA,
Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani IA, Grasso
CS, Kominsky HD, et al: Transcriptome sequencing across a prostate
cancer cohort identifies PCAT-1, an unannotated lincRNA implicated
in disease progression. Nat Biotechnol. 29:742–749. 2011.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Braconi C, Valeri N, Kogure T, Gasparini
P, Huang N, Nuovo GJ, Terracciano L, Croce CM and Patel T:
Expression and functional role of a transcribed noncoding RNA with
an ultraconserved element in hepatocellular carcinoma. Proc Natl
Acad Sci USA. 108:786–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Mourtada-Maarabouni M, Pickard MR, Hedge
VL, Farzaneh F and Williams GT: GAS5, a non-protein-coding RNA,
controls apoptosis and is downregulated in breast cancer. Oncogene.
28:195–208. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Zhang X, Gejman R, Mahta A, Zhong Y, Rice
KA, Zhou Y, Cheunsuchon P, Louis DN and Klibanski A: Maternally
expressed gene 3, an imprinted noncoding RNA gene, is associated
with meningioma pathogenesis and progression. Cancer Res.
70:2350–2358. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Poliseno L, Salmena L, Zhang J, Carver B,
Haveman WJ and Pandolfi PP: A coding-independent function of gene
and pseudogene mRNAs regulates tumour biology. Nature.
465:1033–1038. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Hao Y, Yang X, Zhang D, Luo J and Chen R:
Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits
migration and invasion through Epithelial-Mesenchymal-Transition in
lung cancer. Gene. 608:1–12. 2017. View Article : Google Scholar : PubMed/NCBI
|
17
|
Yang C, Li X, Wang Y, Zhao L and Chen W:
Long non-coding RNA UCA1 regulated cell cycle distribution via CREB
through PI3-K dependent pathway in bladder carcinoma cells. Gene.
496:8–16. 2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Wang JZ, Xiang JJ, Wu LG, Bai YS, Chen ZW,
Yin XQ, Wang Q, Guo WH, Peng Y, Guo H and Xu P: A genetic variant
in long non-coding RNA MALAT1 associated with survival outcome
among patients with advanced lung adenocarcinoma: A survival cohort
analysis. BMC Cancer. 17:1672017. View Article : Google Scholar : PubMed/NCBI
|
19
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA Hypothesis: The Rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Thomson DW and Dinger ME: Endogenous
microRNA sponges: Evidence and controversy. Nat Rev Genet.
17:272–283. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Venables JP, Klinck R, Koh C, Gervais-Bird
J, Bramard A, Inkel L, Durand M, Couture S, Froehlich U, Lapointe
E, et al: Cancer-associated regulation of alternative splicing. Nat
Struct Mol Biol. 16:670–676. 2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Wang SH, Zhang WJ, Wu XC, Zhang MD, Weng
MZ, Zhou D, Wang JD and Quan ZW: Long non-coding RNA Malat1
promotes gallbladder cancer development by acting as a molecular
sponge to regulate miR-206. Oncotarget. 7:37857–37867.
2016.PubMed/NCBI
|
24
|
Popper HH: Progression and metastasis of
lung cancer. Cancer Metastasis Rev. 35:75–91. 2016. View Article : Google Scholar : PubMed/NCBI
|
25
|
Decaussin M, Sartelet H, Robert C, Moro D,
Claraz C, Brambilla C and Brambilla E: Expression of vascular
endothelial growth factor (VEGF) and its two receptors
(VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung
carcinomas (NSCLCs): Correlation with angiogenesis and survival. J
Pathol. 188:369–377. 1999. View Article : Google Scholar : PubMed/NCBI
|
26
|
Suzuki K, Sun R, Origuchi M, Kanehira M,
Takahata T, Itoh J, Umezawa A, Kijima H, Fukuda S and Saijo Y:
Mesenchymal stromal cells promote tumor growth through the
enhancement of neovascularization. Mol Med. 17:579–587. 2011.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Xiang R, Luo Y, Niethammer AG and Reisfeld
RA: Oral DNA vaccines target the tumor vasculature and
microenvironment and suppress tumor growth and metastasis. Immunol
Rev. 222:117–128. 2008. View Article : Google Scholar : PubMed/NCBI
|
28
|
Jiang C, Li X, Zhao H and Liu H: Long
non-coding RNAs: Potential new biomarkers for predicting tumor
invasion and metastasis. Mol Cancer. 15:622016. View Article : Google Scholar : PubMed/NCBI
|
29
|
Rokavec M, Horst D and Hermeking H:
Cellular model of colon cancer progression reveals signatures of
mRNAs, miRNA, lncRNAs, and epigenetic modifications associated with
metastasis. Cancer Res. 77:1854–1867. 2017. View Article : Google Scholar : PubMed/NCBI
|
30
|
Zhang X, Xu J, Wang J, Gortner L, Zhang S,
Wei X, Song J, Zhang Y, Li Q and Feng Z: Reduction of MicroRNA-206
contributes to the development of bronchopulmonary dysplasia
through up-regulation of fibronectin 1. PLoS One. 8:e747502013.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Yen CY, Huang CY, Hou MF, Yang YH, Chang
CH, Huang HW, Chen CH and Chang HW: Evaluating the performance of
fibronectin 1 (FN1), integrin α4β1 (ITGA4), syndecan-2 (SDC2), and
glycoprotein CD44 as the potential biomarkers of oral squamous cell
carcinoma (OSCC). Biomarkers. 18:63–72. 2013. View Article : Google Scholar : PubMed/NCBI
|
32
|
Duan J, Zhang X, Zhang S, Hua S and Feng
Z: miR-206 inhibits FN1 expression and proliferation and promotes
apoptosis of rat type II alveolar epithelial cells. Exp Ther Med.
13:3203–3208. 2017. View Article : Google Scholar : PubMed/NCBI
|
33
|
Nasser MW, Datta J, Nuovo G, Kutay H,
Motiwala T, Majumder S, Wang B, Suster S, Jacob ST and Ghoshal K:
Downregulation of Micro-RNA-1 (miR-1) in lung cancer. Suppression
of tumorigenic property of lung cancer cells and their
sensitization to doxorubicin-induced apoptosis by miR-1. J Biol
Chem. 283:33394–33405. 2008. View Article : Google Scholar : PubMed/NCBI
|
34
|
Grelet S, McShane A, Geslain R and Howe
PH: Pleiotropic roles of non-coding RNAs in TGF-β-mediated
epithelial-mesenchymal transition and their functions in tumor
progression. Cancers (Basel). 9(pii): E752017. View Article : Google Scholar : PubMed/NCBI
|
35
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
36
|
Moustakas A and Heldin CH: Mechanisms of
TGF-β-induced epithelial-mesenchymal transition. J Clin Med.
5:E632016. View Article : Google Scholar : PubMed/NCBI
|
37
|
Lee JK, Joo KM, Lee J, Yoon Y and Nam DH:
Targeting the epithelial to mesenchymal transition in glioblastoma:
The emerging role of fMET signaling. Onco Targets Ther.
7:1933–1944. 2014.PubMed/NCBI
|